SCHEMBL30863610

SCHEMBL30863610

COCCn1ncc(Br)c1NC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ MITF O75030 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GSK3B P49841 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899981 0.80 MEN1 (0.51) CYP2C19MEN1KMT2ANPC1RAB9A
SCHEMBL30863581 0.78 UCHL1 (0.40) CNR1CNR2CYP2C19CYP3A4ALDH1A1
SCHEMBL26008895 0.75 CNR1 (0.40) CNR1CNR2CYP2C19MEN1KMT2A
SCHEMBL31437460 0.74 GSK3B (0.41) CNR1CNR2ALDH1A1MAOAMAOB
SCHEMBL15081325 0.74 MAOA (0.37) CNR1CNR2MAOAMAOBGSK3B
SCHEMBL31437508 0.73 RORC (0.38) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL24896677 0.72 L3MBTL1 (0.46) CNR1CNR2MEN1KMT2AALDH1A1
SCHEMBL27797896 0.72 HDAC3 (0.52) GSK3BHDAC3HDAC8NCOR2
SCHEMBL31017347 0.71 MAPK1 (0.38) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL30895142 0.71 MAPK1 (0.38) MEN1KMT2AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125389-A1 MEMBRANE-ASSOCIATED TYROSINE AND THREONINE KINASE INHIBITOR AND USE THEREOF HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO LTD (CN) 2026-05-07 — — US disclosed
CN-119894902-A Membrane associated tyrosine and threonine kinase inhibitors and uses thereof 海南先声再明医药股份有限公司 2025-04-25 — — CN disclosed
WO-2024061343-A1 MEMBRANE-ASSOCIATED TYROSINE AND THREONINE KINASE INHIBITOR AND USE THEREOF 先声再明医药有限公司 2024-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125389-A1 MEMBRANE-ASSOCIATED TYROSINE AND THREONINE KINASE INHIBITOR AND USE THEREOF PKMYT1, PKN1, ROS1 CNR1 1943/4885CNR2 2690/4885CYP2C19 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback